Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
Contract Pharma

Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
News Medical

Manufacturing processes for active pharmaceutical ingredients (APIs)

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...
News Medical

Lab to plant: Scaling up API processes with Dr. James Mencel's guidance

In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...

Small Molecule API Market Size to Reach USD 328.03 Billion by 2033, Driven by Rising Demand for Cost-Effective Therapeutics – SNS Insider

Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...
ksn.com

INTERNATIONAL PROCESS PLANTS ANNOUNCES PURCHASE OF WORLD-CLASS GRIMSBY, UK API PHARMACEUTICAL MANUFACTURING SITE FROM NOVARTIS

"We are very excited to transition this fully-integrated API Pharmaceutical site, with its substantial reaction capacity, site infrastructure and attractive location, we are confident in the potential ...